Greenwich Wealth Management »

Annovis Bio shares owned by Greenwich Wealth Management

Quarter-by-quarter ownership of Annovis Bio (ANVS) shares owned by Greenwich Wealth Management from 13F filings

Historical chart of Greenwich Wealth Management investment in Annovis Bio

Tip: Access up to 7 years of quarterly data

All positions including Annovis Bio held by Greenwich Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annovis Bio by Greenwich Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $192k 10k 18.69

More positions owned by Greenwich Wealth Management

Interactive Brokers Group In Cl A (IBKR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Oracle Corporation (ORCL)
Microsoft Corporation (MSFT)
Weyerhaeuser Company (WY)
Franklin Resources (BEN)
Janus Detroit Str Tr Hendrson Aaa CL (JAAA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Regeneron Pharmaceuticals (REGN)
Oppenheimer Hldgs Cl A Non Vtg (OPY)
CBOE Holdings (CBOE)
Goldman Sachs (GS)
UnitedHealth (UNH)

View all positions for Greenwich Wealth Management

Top funds holding Annovis Bio

Vanguard Group
Citadel Advisors
Sterling Investment Advisors
Redmond Asset Management
Marshall Wace
Modera Wealth Management
Cutler
Merit Financial Group
Bank of New York Mellon
Two Sigma Securities
Jane Street
Gts Securities
Citigroup
Dimensional Fund Advisors
Sontag Advisory

View all funds holding Annovis Bio